Roy Baynes

Insider profile

Currently holds a position at Natera Inc

Performance

Overall performance
0.5

Performance over holding periods
0.5
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Roy Baynes's trades of Travere Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-16 2026-06-12 PlS Planned sale
23,810 +24.7%
347.44
US$3,483,999
23,810 +24.7% 347.44 US$3,483,999
2026-06-12 2026-06-12 PrS Proposed sale
54,170
161.52
US$2,410,536
54,170 161.52 US$2,410,536
2026-05-06 2026-05-05 PlS Planned sale
42,018 +21.2%
212.29
US$3,234,066
42,018 +21.2% 212.29 US$3,234,066
2026-05-05 2026-05-05 PrS Proposed sale
4,500
46.65
US$209,925
4,500 46.65 US$209,925
2026-05-04 2026-05-01 PlS Planned sale
9,750 -20.6%
44.22
US$431,145
9,750 -20.6% 44.22 US$431,145
2026-05-01 2026-05-01 PrS Proposed sale
9,750
44.22
US$431,145
9,750 44.22 US$431,145
2026-04-16 2026-04-14 PlS Planned sale
6,750 -15.3%
42.12
US$284,310
6,750 -15.3% 42.12 US$284,310
2026-04-16 2026-04-14 PlS Planned sale
26,000 -37.0%
41.07
US$1,067,820
26,000 -37.0% 41.07 US$1,067,820
2026-04-14 2026-04-14 PrS Proposed sale
32,750
41.29
US$1,352,130
32,750 41.29 US$1,352,130
2026-04-07 2026-04-06 PlS Planned sale
10,000 -21.1%
33.00
US$330,000
10,000 -21.1% 33.00 US$330,000
2026-04-06 2026-04-06 PrS Proposed sale
10,000
33.00
US$330,000
10,000 33.00 US$330,000
2025-11-21 2025-11-20 PlS Planned sale
1,884 -9.3%
224.89
US$423,685
1,884 -9.3% 224.89 US$423,685
2025-11-21 2025-11-20 PlS Planned sale
1,900 -8.6%
223.90
US$425,417
1,900 -8.6% 223.90 US$425,417
2025-11-21 2025-11-20 PlS Planned sale
1,800 -7.5%
222.90
US$401,220
1,800 -7.5% 222.90 US$401,220
2025-11-21 2025-11-20 PlS Planned sale
900 -3.6%
221.81
US$199,632
900 -3.6% 221.81 US$199,632
2025-11-21 2025-11-20 PlS Planned sale
1,184 -4.5%
220.14
US$260,646
1,184 -4.5% 220.14 US$260,646
2025-11-20 2025-11-20 PrS Proposed sale
7,668
223.08
US$1,710,600
7,668 223.08 US$1,710,600
2025-11-21 2025-11-19 PlS Planned sale
2,135 -10.4%
216.07
US$461,304
2,135 -10.4% 216.07 US$461,304
2025-11-21 2025-11-19 PlS Planned sale
1,727 -7.8%
214.79
US$370,946
1,727 -7.8% 214.79 US$370,946
2025-11-21 2025-11-19 PlS Planned sale
1,250 -5.3%
213.47
US$266,839
1,250 -5.3% 213.47 US$266,839
2025-11-19 2025-11-19 PrS Proposed sale
5,112
215.00
US$1,099,088
5,112 215.00 US$1,099,088
2025-02-10 2025-02-06 PlS Planned sale
10,000 -24.4%
22.00
US$220,000
10,000 -24.4% 22.00 US$220,000
2025-02-06 2025-02-06 PrS Proposed sale
10,000
22.00
US$220,000
10,000 22.00 US$220,000
2025-01-23 2025-01-23 PrS Proposed sale
16,000
20.00
US$320,000
16,000 20.00 US$320,000
2025-01-23 2025-01-23 PlS Planned sale
16,000 -34.0%
20.00
US$320,000
16,000 -34.0% 20.00 US$320,000
2024-11-15 2024-11-15 PrS Proposed sale
37,230
146.11
US$5,439,564
37,230 146.11 US$5,439,564
2024-11-15 2024-11-15 PlS Planned sale
1,983 -11.1%
149.98
US$297,408
1,983 -11.1% 149.98 US$297,408
2024-11-15 2024-11-15 PlS Planned sale
2,106 -10.6%
148.74
US$313,250
2,106 -10.6% 148.74 US$313,250
2024-11-15 2024-11-15 PlS Planned sale
9,467 -32.2%
147.31
US$1,394,620
9,467 -32.2% 147.31 US$1,394,620
2024-11-15 2024-11-15 PlS Planned sale
1,770 -5.7%
146.26
US$258,871
1,770 -5.7% 146.26 US$258,871
2024-11-15 2024-11-15 PlS Planned sale
16,404 -34.5%
145.21
US$2,381,997
16,404 -34.5% 145.21 US$2,381,997
2024-11-15 2024-11-15 PlS Planned sale
5,500 -10.4%
144.26
US$793,419
5,500 -10.4% 144.26 US$793,419
2020-08-11 2020-08-07 S Sale
1,300 -100.0%
53.47
US$69,513
1,300 -100.0% 53.47 US$69,513